Neurofeedback trials

Neurofeedback for Bipolar Disorder

RecruitingNCT05802446Phase: NAStarted 2024-05-22

Summary

Bipolar Disorder (BD) is a severe mood disorder affecting between 1% and 3% of the general population. It is characterized by the succession of depressive and manic episodes, with periods of stabiliza

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Locations

Albert ChenevierCréteil, val-de-marne, France

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT05802446